Aptamers are single-stranded DNA or RNA oligonucleotides that fold into defined three-dimensional structures, enabling high-affinity and high-specificity binding to target proteins in a manner analogous to antibodies ( Recent large-scale proteomic analysis of semaglutide therapy in individuals with overweight or obesity, with or without type 2 diabetes, demonstrated a distinct proteomic signature following treatment ( These findings support aptamer-based proteomics as a promising translational tool for identifying GLP-1RA-responsive vascular pathways, and monitoring therapeutic molecular responses
In the observational study, 25% of patients reported curvature improvement, 56% reported plaque improvement, and 100% reported pain improvement
With its potential to boost energy expenditure and improve insulin sensitivity, this peptide can support overall metabolic health
Mar, M
Muldoon LL, Wu YJ, Pagel MA, Neuwelt EA
(ISBN: 978-1-4052-3648-8)